Moderna is under fire after financial records showed the biotech company’s CEO Stephane Bancel earned around $393 million in 2022 from stock options he exercised as he received a 50% raise.
Bancel, whose firm is known for producing the COVID-19 vaccine, received $1.5 million in 2022, an increase of 50% from 2021, and Moderna increased his target cash bonus, a March securities and exchange commission filing shows.
Read More
Pharmaceutical company Moderna announced Monday that it will submit its coronavirus vaccine to the federal government for emergency use authorization approval.
Moderna said it would ask the Food and Drug Administration (FDA) for approval after its large-scale human trial concluded and showed the company’s vaccine to have an overall efficacy of 94.1%, according to NBC News. The vaccine was found to be 100% effective in preventing severe cases of coronavirus, according to Moderna.
Read More
Biotech company Moderna announced Monday that its new COVID-19 vaccine has proven to be 94.5 % effective.
The company said it intends to submit for an Emergency Use Authorization (EUA) with the U.S. Food and Drug Administration in the coming weeks and expects the EUA to be based on the final analysis of 151 cases and a median follow-up of more than two months.
Read More